References:
1. Ruda R, Soffietti R. What is New in the Management of Epilepsy in Gliomas? Curr Treat Options Neurol. 2015;17(6):351.
2. Mulcahy Levy JM, McMahon M. Linking brain tumors and epileptic seizures. Nature Medicine. 2018;24(11):1638-9.
3. Holthausen H, Blumcke I. Epilepsy-associated tumours: what epileptologists should know about neuropathology, terminology, and classification systems. Epileptic Disord. 2016;18(3):240-51.
4. Luzzi S, Elia A, Del Maestro M, Elbabaa SK, Carnevale S, Guerrini F, et al. Dysembryoplastic Neuroepithelial Tumors: What You Need to Know. World Neurosurg. 2019;127:255-65.
5. Lassaletta A, Zapotocky M, Mistry M, Ramaswamy V, Honnorat M, Krishnatry R, et al. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas. J Clin Oncol. 2017;35(25):2934-41.
6. Phi JH, Kim SK. Clinical Pearls and Advances in Molecular Researches of Epilepsy-Associated Tumors. J Korean Neurosurg Soc. 2019;62(3):313-20.
7. Blumcke I, Budday S, Poduri A, Lal D, Kobow K, Baulac S. Neocortical development and epilepsy: insights from focal cortical dysplasia and brain tumours. The Lancet Neurology. 2021;20(11):943-55.
8. Luyken C, Blumcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, et al. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia. 2003;44(6):822-30.
9. Huberfeld G, Vecht CJ. Seizures and gliomas–towards a single therapeutic approach. Nat Rev Neurol. 2016;12(4):204-16.
10. Battaglia DI, Gambardella ML, Veltri S, Contaldo I, Chillemi G, Veredice C, et al. Epilepsy and BRAF Mutations: Phenotypes, Natural History and Genotype-Phenotype Correlations. Genes (Basel). 2021;12(9).
11. Slegers RJ, Blumcke I. Low-grade developmental and epilepsy associated brain tumors: a critical update 2020. Acta Neuropathol Commun. 2020;8(1):27.
12. Stone TJ, Rowell R, Jayasekera BAP, Cunningham MO, Jacques TS. Review: Molecular characteristics of long-term epilepsy-associated tumours (LEATs) and mechanisms for tumour-related epilepsy (TRE). Neuropathol Appl Neurobiol. 2018;44(1):56-69.
13. Xing H, Song Y, Zhang Z, Koch PD. Clinical Characteristics of BRAF V600E Gene Mutation in Patients of Epilepsy-Associated Brain Tumor: a Meta-analysis. J Mol Neurosci. 2021;71(9):1815-24.
14. Marucci G, de Biase D, Visani M, Giulioni M, Martinoni M, Volpi L, et al. Mutant BRAF in low-grade epilepsy-associated tumors and focal cortical dysplasia. Ann Clin Transl Neurol. 2014;1(2):130-4.
15. Perez JPM, Muchart J, Lopez VS, Capella MS, Salvador N, Jaume SP, et al. Targeted therapy for pediatric low-grade glioma. Childs Nerv Syst. 2021.
16. Koh HY, Kim SH, Jang J, Kim H, Han S, Lim JS, et al. BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors. Nat Med. 2018;24(11):1662-8.